DOES IMMUNOSUPPRESSIVE TREATMENT AMELIORATE MORPHOLOGY CHANGES IN ENCAPSULATING PERITONEAL SCLEROSIS?
Makaleler > Tam Makale · 2009
Yazarlar: Devrim BOZKURT, Savas SIPAHI, Pinar CETIN, Ender HUR, Ozden OZDEMIR, Muhittin ERTILAV, Sait ŞEN, Soner DUMAN
PERITONEAL DIALYSIS INTERNATIONAL, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2009, cilt 29
Özet
Encapsulating peritoneal sclerosis (EPS) is a clinical syndrome associated with ileus symptoms and irreversible sclerosis of the peritoneal membrane. Inflammation, fibrosis, and neoangiogenesis are the main features of the pathophysiology. No evidence-based therapy is currently available for EPS. In recent years, anti-inflammatory and immunosuppressive (IS) treatment modalities have become more popular.